NASDAQ:ACON Aclarion (ACON) Stock Price, News & Analysis $7.21 -0.09 (-1.23%) Closing price 03:46 PM EasternExtended Trading$7.19 -0.02 (-0.29%) As of 04:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock About Aclarion Stock (NASDAQ:ACON) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Aclarion alerts:Sign Up Key Stats Today's Range$7.17▼$7.3250-Day Range$6.80▼$7.8452-Week Range$6.20▼$3,499.51Volume7,511 shsAverage Volume92,883 shsMarket Capitalization$4.18 millionP/E RatioN/ADividend YieldN/APrice Target$11,758.50Consensus RatingHold Company Overview Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado. Read More Aclarion Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks38th Percentile Overall ScoreACON MarketRank™: Aclarion scored higher than 38% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.0 / 5Analyst RatingHold Consensus RatingAclarion has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageAclarion has only been the subject of 1 research reports in the past 90 days.Read more about Aclarion's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Aclarion are expected to grow in the coming year, from ($263.33) to ($216.67) per share.Price to Book Value per Share RatioAclarion has a P/B Ratio of 0.14. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Aclarion's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.06% of the float of Aclarion has been sold short.Short Interest Ratio / Days to CoverAclarion has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Aclarion has recently increased by 11.32%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAclarion does not currently pay a dividend.Dividend GrowthAclarion does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted3.06% of the float of Aclarion has been sold short.Short Interest Ratio / Days to CoverAclarion has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Aclarion has recently increased by 11.32%, indicating that investor sentiment is decreasing significantly. News and Social MediaN/ANews SentimentN/A Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Aclarion insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.77% of the stock of Aclarion is held by insiders.Percentage Held by InstitutionsOnly 7.52% of the stock of Aclarion is held by institutions.Read more about Aclarion's insider trading history. Receive ACON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aclarion and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ACON Stock News HeadlinesAclarion, Inc. (ACON) - Yahoo FinanceAugust 12, 2025 | sg.finance.yahoo.comAclarion Provides Corporate Update Highlighting Scan Volume Growth and Key Upcoming CatalystsAugust 5, 2025 | globenewswire.comThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because there's a $15 fund tied directly to gold's surge that's still paying massive income… Up to 64% annually — with payouts every 30 days.August 26 at 2:00 AM | Investors Alley (Ad)Aclarion, Inc. Adjourns Annual Meeting to Solicit VotesJuly 30, 2025 | theglobeandmail.comAclarion, Inc. Announces Adjournment of Annual Meeting of StockholdersJuly 7, 2025 | globenewswire.comACON - Aclarion Inc Ordinary Shares Chart - MorningstarJuly 4, 2025 | morningstar.comMAclarion Enrolls First Patient In CLARITY Trial Evaluating Nociscan In Spine Surgery - NasdaqJune 27, 2025 | nasdaq.comFirst Patient Enrolled in Aclarion's Groundbreaking CLARITY TrialJune 25, 2025 | globenewswire.comSee More Headlines ACON Stock Analysis - Frequently Asked Questions How have ACON shares performed this year? Aclarion's stock was trading at $1,302.48 at the start of the year. Since then, ACON shares have decreased by 99.5% and is now trading at $7.1550. How were Aclarion's earnings last quarter? Aclarion, Inc. (NASDAQ:ACON) posted its quarterly earnings results on Thursday, August, 14th. The company reported ($2.75) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($2.26) by $0.49. The company earned $0.02 million during the quarter, compared to analyst estimates of $0.03 million. Aclarion had a negative net margin of 11,238.59% and a negative trailing twelve-month return on equity of 83.63%. When did Aclarion's stock split? Aclarion's stock reverse split on Friday, March 28th 2025.The 1-27 reverse split was announced on Wednesday, March 26th 2025. The number of shares owned by shareholders was adjusted after the market closes on Thursday, March 27th 2025. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split. When did Aclarion IPO? Aclarion (ACON) raised $12 million in an initial public offering on Friday, April 22nd 2022. The company issued 2,165,000 shares at a price of $4.50-$6.50 per share. How do I buy shares of Aclarion? Shares of ACON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Aclarion own? Based on aggregate information from My MarketBeat watchlists, some other companies that Aclarion investors own include Broadcom (AVGO), Meta Platforms (META), Norwegian Cruise Line (NCLH), Audioeye (AEYE), Advanced Micro Devices (AMD), ASML (ASML) and AvidXchange (AVDX). Company Calendar Last Earnings8/14/2025Today8/26/2025Next Earnings (Estimated)11/13/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Services Sub-IndustryHealthcare Current SymbolNASDAQ:ACON CIK1635077 Webwww.aclarion.com Phone833-275-2266FaxN/AEmployees7Year FoundedN/APrice Target and Rating Average Price Target for Aclarion$11,758.50 High Price Target$11,758.50 Low Price Target$11,758.50 Potential Upside/Downside+164,239.6%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$6.99 million Net Margins-11,238.59% Pretax Margin-11,238.59% Return on Equity-83.63% Return on Assets-76.55% Debt Debt-to-Equity RatioN/A Current Ratio23.83 Quick Ratio23.83 Sales & Book Value Annual Sales$50 thousand Price / Sales83.00 Cash FlowN/A Price / Cash FlowN/A Book Value$51.50 per share Price / Book0.14Miscellaneous Outstanding Shares580,000Free Float578,000Market Cap$4.15 million OptionableNot Optionable Beta1.34 Social Links The Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:ACON) was last updated on 8/26/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredTrump’s SHOCKING Plan to Create MASSIVE Wealth for AmericansJames Altucher says Donald Trump just made a move so surprising, it could go down as the most lucrative presid...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclarion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aclarion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.